Sarepta Therapeutics
SRPT
SRPT
353 hedge funds and large institutions have $1.41B invested in Sarepta Therapeutics in 2025 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 158 increasing their positions, 84 reducing their positions, and 128 closing their positions.
Holders
353
Holders Change
-74
Holders Change %
-17.33%
% of All Funds
4.74%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
63
Increased
158
Reduced
84
Closed
128
Calls
$107M
Puts
$69.5M
Net Calls
+$37.4M
Net Calls Change
+$16.3M
Top Buyers
1 |
1
D.E. Shaw & Co
New York
|
$76.6M |
2 |
2
BlackRock
New York
|
$207M |
3 |
3
Two Sigma Advisers
New York
|
$34M |
4 |
4
Two Sigma Investments
New York
|
$37M |
5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$27.3M |